|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
DE2010115A1
(de)
|
1970-03-04 |
1971-09-16 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Verfahren zur Herstellung von Mikrogranulaten
|
|
US4389330A
(en)
|
1980-10-06 |
1983-06-21 |
Stolle Research And Development Corporation |
Microencapsulation process
|
|
US4675189A
(en)
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
|
US4474572A
(en)
|
1981-09-29 |
1984-10-02 |
Syntex (U.S.A.) Inc. |
Implanting device and implant magazine
|
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
|
US4758435A
(en)
|
1986-08-11 |
1988-07-19 |
American Cyanamid Company |
Estradiol implant composition and method for preparation
|
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
|
US4900552A
(en)
|
1988-03-30 |
1990-02-13 |
Watson Laboratories, Inc. |
Mucoadhesive buccal dosage forms
|
|
AU6952391A
(en)
|
1989-11-29 |
1991-06-26 |
Brigham And Women's Hospital |
(ala il-8)77 as a leukocyte adhesion inhibitor
|
|
US6221367B1
(en)
|
1992-06-15 |
2001-04-24 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
|
US5122377A
(en)
*
|
1990-11-19 |
1992-06-16 |
A.H. Robins, Company, Incorporated |
Oral delivery system for veterinary drugs
|
|
EP0551626A1
(en)
|
1991-12-19 |
1993-07-21 |
LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. |
Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
ES2113094T3
(es)
|
1993-03-09 |
1998-04-16 |
Epic Therapeutics Inc |
Las microparticulas macromoleculares y metodos de obtencion.
|
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
US5421818A
(en)
|
1993-10-18 |
1995-06-06 |
Inner Ear Medical Delivery Systems, Inc. |
Multi-functional inner ear treatment and diagnostic system
|
|
TW438601B
(en)
|
1994-05-18 |
2001-06-07 |
Janssen Pharmaceutica Nv |
New mucoadhesive emulsion compositions and a process for the preparation thereof
|
|
AU698393B2
(en)
|
1994-06-24 |
1998-10-29 |
Immunex Corporation |
Controlled release polypeptide compositions and methods of treating inflammatory bowel disease
|
|
GB9505032D0
(en)
|
1995-03-13 |
1995-05-03 |
Westminster Lab Ltd |
Improvements in or relating to organic compositions
|
|
IL112834A
(en)
|
1995-03-01 |
2000-12-06 |
Yeda Res & Dev |
Pharmaceutical compositions for controlled release of soluble receptors
|
|
FR2742357B1
(fr)
|
1995-12-19 |
1998-01-09 |
Rhone Poulenc Rorer Sa |
Nanoparticules stabilisees et filtrables dans des conditions steriles
|
|
US6379911B2
(en)
|
1996-02-23 |
2002-04-30 |
Albert Einstein College Of Medicine Of Yeshiva University |
Enzyme detection/assay method and substrates
|
|
NZ333650A
(en)
|
1996-07-19 |
2000-02-28 |
Amgen Inc |
Analogs of cationic proteins like NT-3 (neurotrophin-3) and BDNF (brain derived neurotrophic factor) that are circulated more readily due to a lower isoelectric point and a lower protein charge relative to the native protein
|
|
US5945126A
(en)
|
1997-02-13 |
1999-08-31 |
Oakwood Laboratories L.L.C. |
Continuous microsphere process
|
|
US6045528A
(en)
|
1997-06-13 |
2000-04-04 |
Intraear, Inc. |
Inner ear fluid transfer and diagnostic system
|
|
US5939421A
(en)
|
1997-07-01 |
1999-08-17 |
Signal Pharmaceuticals, Inc. |
Quinazoline analogs and related compounds and methods for treating inflammatory conditions
|
|
DE69833000T2
(de)
|
1997-09-26 |
2006-09-07 |
Noven Pharmaceuticals, Inc., Miami |
Bio-klebemittelzusammensetzungen
|
|
US5985848A
(en)
|
1997-10-14 |
1999-11-16 |
Albert Einstein College Of Medicine Of Yeshiva University |
Inhibitors of nucleoside metabolism
|
|
GB9812426D0
(en)
|
1998-06-10 |
1998-08-05 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
|
US6319513B1
(en)
|
1998-08-24 |
2001-11-20 |
The Procter & Gamble Company |
Oral liquid mucoadhesive compounds
|
|
US20020009478A1
(en)
|
1998-08-24 |
2002-01-24 |
Douglas Joseph Dobrozsi |
Oral liquid mucoadhesive compositions
|
|
US6270802B1
(en)
|
1998-10-28 |
2001-08-07 |
Oakwood Laboratories L.L.C. |
Method and apparatus for formulating microspheres and microcapsules
|
|
PT1165564E
(pt)
|
1999-04-08 |
2009-04-16 |
Einstein Coll Med |
Processo para a preparação de inibidores do metabolismo de nucleósidos
|
|
US6537540B1
(en)
|
1999-05-28 |
2003-03-25 |
Targeted Genetics Corporation |
Methods and composition for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders
|
|
HK1047582B
(zh)
|
1999-06-23 |
2005-03-04 |
萨诺费－阿文蒂斯德国有限公司 |
取代的苯並咪唑
|
|
US6458387B1
(en)
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
|
DE19951360A1
(de)
|
1999-10-26 |
2001-05-03 |
Aventis Pharma Gmbh |
Substituierte Indole
|
|
JP4879433B2
(ja)
|
2000-01-13 |
2012-02-22 |
エミスフェアー・テクノロジーズ・インク |
活性剤を送達するための化合物および組成物
|
|
GB0003154D0
(en)
|
2000-02-12 |
2000-04-05 |
Astrazeneca Uk Ltd |
Novel compounds
|
|
EP1268477B1
(en)
|
2000-03-15 |
2010-04-21 |
Sanofi-Aventis Deutschland GmbH |
Substituted beta-carbolines with ikb-kinase inhibiting activity
|
|
IL153375A0
(en)
|
2000-06-22 |
2003-07-06 |
Genentech Inc |
Agonist anti-trk-c monoclonal antibodies
|
|
US20020013331A1
(en)
|
2000-06-26 |
2002-01-31 |
Williams Robert O. |
Methods and compositions for treating pain of the mucous membrane
|
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
|
WO2002018371A1
(en)
|
2000-08-29 |
2002-03-07 |
Industrial Research Limited |
Nucleoside metabolism inhibitors
|
|
JP4272338B2
(ja)
|
2000-09-22 |
2009-06-03 |
バイエル アクチェンゲゼルシャフト |
ピリジン誘導体
|
|
HUP0303696A3
(en)
*
|
2000-09-25 |
2005-05-30 |
Bayer Healthcare Llc Tarrytown |
Otic microbial combinations for treatment of animals with ruptured tympanic membrane
|
|
EP1328272A1
(en)
|
2000-10-12 |
2003-07-23 |
SmithKline Beecham Corporation |
Nf-kappa-b inhibitors
|
|
AU2002211663A1
(en)
|
2000-10-12 |
2002-04-22 |
Smith Kline Beecham Corporation |
Nf-$g(k)b inhibitors
|
|
CN1503673A
(zh)
|
2000-10-26 |
2004-06-09 |
�㽭�пؼ����ɷ�����˾ |
消炎药
|
|
JP2002193938A
(ja)
|
2000-12-01 |
2002-07-10 |
Bayer Ag |
４−アリールピリジン誘導体
|
|
US7122544B2
(en)
|
2000-12-06 |
2006-10-17 |
Signal Pharmaceuticals, Llc |
Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
|
|
EP1370139A4
(en)
|
2001-01-04 |
2010-09-22 |
Einstein Coll Med |
INHIBITORS OF ADP-RIBOSYLTRANSFERASES, CYCLASES AND HYDROLASES AND THEIR USE
|
|
SE0100158D0
(sv)
|
2001-01-19 |
2001-01-19 |
Synphora Ab |
Novel method and composition for local treatment of Meniere´s disease and tinnitus
|
|
CZ20032287A3
(cs)
|
2001-02-01 |
2004-02-18 |
Bristol-Myers Squibb Company |
Způsoby léčení zánětlivých a imunitních nemocí za použití inhibitorů IkB kinázy (IKK)
|
|
FR2823441B1
(fr)
*
|
2001-04-12 |
2004-09-10 |
Thea Lab |
Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
|
|
WO2002094265A1
(en)
|
2001-05-24 |
2002-11-28 |
Leo Pharma A/S |
A method of modulating nf-$g(k)b activity
|
|
US20030045515A1
(en)
|
2001-05-24 |
2003-03-06 |
Lise Binderup |
Combination medicament for treatment of neoplastic diseases
|
|
SE0102617D0
(sv)
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
|
CA2460939C
(en)
|
2001-09-19 |
2008-07-29 |
Pharmacia Corporation |
Substituted pyrazolyl compounds for the treatment of inflammation
|
|
EP1444207A2
(en)
|
2001-09-19 |
2004-08-11 |
Pharmacia Corporation |
Substituted pyrazolyl-compounds for the treatment of inflammation
|
|
US7166639B2
(en)
|
2001-10-04 |
2007-01-23 |
Smithkline Beecham Corporation |
NF-κB inhibitors
|
|
CA2467854A1
(en)
|
2001-11-21 |
2003-06-05 |
Vern L. Schramm |
Sir2 products and activities
|
|
MXPA04005427A
(es)
|
2001-12-10 |
2005-04-19 |
Amgen Inc |
Ligandos de receptor vainilloide y su uso en tratamientos.
|
|
RS63204A
(sr)
|
2002-01-17 |
2006-10-27 |
Neurogen Corporation |
Supstituisani analozi hinazolin-4-ilamina kao modulatori kapsaicina
|
|
JP2003277383A
(ja)
|
2002-03-14 |
2003-10-02 |
Bayer Ag |
光学活性ピリジン誘導体およびそれを含む医薬
|
|
US7098334B2
(en)
|
2002-03-25 |
2006-08-29 |
Industrial Research Limited |
4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
|
|
JP2005531574A
(ja)
|
2002-05-22 |
2005-10-20 |
アムジエン・インコーポレーテツド |
痛みの治療にバニロイド受容体リガンドとして使用するためのアミノ−ピリジン、−ピリジンおよびピリダジン誘導体
|
|
US7022680B2
(en)
|
2002-05-30 |
2006-04-04 |
Albert Einstein College Of Medicine Of Yeshiva University |
Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases
|
|
FR2841243B1
(fr)
*
|
2002-06-19 |
2004-08-20 |
Servier Lab |
Nouveaux derives de 3-(4-oxo-4h-chromen-2yl)-(1h)-quinolein- 4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
TW200410945A
(en)
|
2002-08-08 |
2004-07-01 |
Amgen Inc |
Vanilloid receptor ligands and their use in treatments"
|
|
US7220431B2
(en)
*
|
2002-11-27 |
2007-05-22 |
Regents Of The University Of Minnesota |
Methods and compositions for applying pharmacologic agents to the ear
|
|
US7582635B2
(en)
|
2002-12-24 |
2009-09-01 |
Purdue Pharma, L.P. |
Therapeutic agents useful for treating pain
|
|
US20040185047A1
(en)
|
2003-03-21 |
2004-09-23 |
Jill Giles-Komar |
Anti- TNF antibodies, compositions, methods and uses
|
|
US7279499B2
(en)
|
2003-04-21 |
2007-10-09 |
Eli Lilly And Company |
Substituted benzopyrans as selective estrogen receptor-beta agonists
|
|
US20040247575A1
(en)
|
2003-06-03 |
2004-12-09 |
Caplice Noel M. |
Smooth muscle progenitor cells
|
|
US7329664B2
(en)
|
2003-07-16 |
2008-02-12 |
Neurogen Corporation |
Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues
|
|
EP1648878B9
(en)
|
2003-07-24 |
2011-03-16 |
Euro-Celtique S.A. |
Piperidine compounds and pharmaceutical compositions containing them
|
|
US7390907B2
(en)
|
2003-09-30 |
2008-06-24 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
JP4503617B2
(ja)
|
2003-12-23 |
2010-07-14 |
ライナット ニューロサイエンス コーポレイション |
アゴニスト抗ｔｒｋＣ抗体および該抗体を用いる方法
|
|
US7312330B2
(en)
|
2003-12-24 |
2007-12-25 |
Renovis, Inc. |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
|
TW200530235A
(en)
|
2003-12-24 |
2005-09-16 |
Renovis Inc |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
|
US20060063802A1
(en)
*
|
2004-03-29 |
2006-03-23 |
Matthieu Guitton |
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
|
|
US8268866B2
(en)
|
2004-03-29 |
2012-09-18 |
Matthieu Guitton |
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
|
|
EP1747215A1
(en)
|
2004-05-12 |
2007-01-31 |
Aventis Pharmaceuticals, Inc. |
Substantially pure 2-{¬2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl|-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor
|
|
WO2005115527A2
(en)
|
2004-05-24 |
2005-12-08 |
Auris Medical, Llc. |
Combined otic aspirator and medication dispenser
|
|
US8498681B2
(en)
|
2004-10-05 |
2013-07-30 |
Tomophase Corporation |
Cross-sectional mapping of spectral absorbance features
|
|
US20060105967A1
(en)
|
2004-11-18 |
2006-05-18 |
Advanced Gene Technology, Corp. |
Flavone derivatives as TNFalpha inhibitors or antagonists
|
|
UA92731C2
(ru)
*
|
2004-12-09 |
2010-12-10 |
Баер Энимал Хелс Гмбх |
Лекарственное средство для гигиеничной обработки уха
|
|
DE102005055385A1
(de)
*
|
2004-12-09 |
2006-06-14 |
Bayer Healthcare Ag |
Arzneimittel zur hygienischen Applikation im Ohr
|
|
AU2005313601B2
(en)
*
|
2004-12-09 |
2012-05-24 |
Bayer Intellectual Property Gmbh |
Stabilisation of glucocorticoid esters with acids
|
|
WO2006076318A1
(en)
|
2005-01-12 |
2006-07-20 |
Aventis Pharmaceuticals Inc. |
Monopotassium salt of an ikb kinase inhibitor
|
|
AU2006204699B2
(en)
|
2005-01-13 |
2012-04-26 |
Sirtris Pharmaceuticals, Inc. |
Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
|
|
CA2593482A1
(en)
|
2005-01-14 |
2006-07-20 |
Neurogen Corporation |
Heteroaryl substituted quinolin-4-ylamine analogues
|
|
AU2006208042A1
(en)
|
2005-01-25 |
2006-08-03 |
Neurogen Corporation |
Substituted pyridazinyl-and pyrimidinyl-quinolin-4-ylamine analogues
|
|
US20060221197A1
(en)
|
2005-03-30 |
2006-10-05 |
Jung Edward K |
Image transformation estimator of an imaging device
|
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
EP2932971A1
(en)
*
|
2005-03-04 |
2015-10-21 |
Otonomy, Inc. |
Ketamine formulations
|
|
EP1858865B1
(en)
|
2005-03-10 |
2009-09-16 |
Pfizer Inc. |
Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
|
|
US7312233B2
(en)
|
2005-03-14 |
2007-12-25 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
EA200701745A1
(ru)
|
2005-03-17 |
2008-06-30 |
Пфайзер, Инк. |
Циклопропанкарбоксамидные производные
|
|
ES2382876T3
(es)
|
2005-05-31 |
2012-06-14 |
Pfizer, Inc. |
Compuestos de ariloxi-N-biciclometil-acetamida sustituidos como antagonistas de VR1
|
|
US7785834B2
(en)
|
2005-11-10 |
2010-08-31 |
Ercole Biotech, Inc. |
Soluble TNF receptors and their use in treatment of disease
|
|
US20070219272A1
(en)
|
2006-02-06 |
2007-09-20 |
Johan Stjernschantz |
Novel method and compositions for treatment of tinnitus
|
|
TWI446757B
(zh)
|
2006-03-24 |
2014-07-21 |
Lg Electronics Inc |
在無線通訊系統中設定前文以支援資料符號之傳輸的方法和架構
|
|
US7744746B2
(en)
|
2006-03-31 |
2010-06-29 |
Exxonmobil Research And Engineering Company |
FCC catalyst stripper configuration
|
|
CN103349659A
(zh)
*
|
2006-09-26 |
2013-10-16 |
塔罗制药北美有限公司 |
液体药物组合物以及应用
|
|
US8377898B2
(en)
|
2006-10-12 |
2013-02-19 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
|
|
CA2672750A1
(en)
|
2006-12-20 |
2008-07-03 |
Rinat Neuroscience Corporation |
Trkb agonists for treating autoimmune disorders
|
|
EP2254572B1
(en)
|
2008-02-07 |
2013-10-16 |
Massachusetts Eye & Ear Infirmary |
Compounds that enhance atoh-1 expression
|
|
WO2009132050A2
(en)
|
2008-04-21 |
2009-10-29 |
Otonomy, Inc. |
Auris formulations for treating otic diseases and conditions
|
|
WO2012027821A1
(en)
|
2010-09-03 |
2012-03-08 |
The Royal Institution For The Advancement Of Learning / Mcgill University |
A trkc receptor agonist antibody to treat neurodegenerative and motor neuron diseases
|
|
US9125894B2
(en)
|
2010-10-06 |
2015-09-08 |
Massachusetts Eye & Ear Infirmary |
Methods for promoting reinnervation of auditory hair cells
|
|
EP2667881A4
(en)
|
2011-01-24 |
2015-04-22 |
Univ Leland Stanford Junior |
METHOD FOR IN VITRO GENERATION OF INTERNAL CELLS
|
|
US20140234227A1
(en)
*
|
2011-10-10 |
2014-08-21 |
Otic Pharma Ltd. |
Foam formulations
|
|
DE202012100195U1
(de)
|
2012-01-19 |
2012-03-01 |
Nordmark Arzneimittel Gmbh & Co. Kg |
Neue Verwendung einer pharmazeutischen Zusammensetzung, enthaltend Ancrod
|
|
WO2013124416A1
(en)
|
2012-02-23 |
2013-08-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Calcineurin inhibitors for use in the treatment of lesional vestibular disorders
|
|
WO2013173803A2
(en)
*
|
2012-05-17 |
2013-11-21 |
Michael Spector |
Formulations of amoxicillin and clavulanate potassium and methods for using same
|
|
HK1209040A1
(en)
|
2012-05-30 |
2016-03-24 |
Sensorion |
Methods for treating vestibulotoxicity
|
|
HUE039713T2
(hu)
|
2012-06-08 |
2019-02-28 |
Sensorion |
H4 receptor inhibitorok tinnitus kezelésére
|
|
EP2892506B1
(en)
|
2012-09-07 |
2021-11-03 |
Massachusetts Eye & Ear Infirmary |
Treating hearing loss with the gamma-secretase inhibitor ly411575
|
|
EP2853533A1
(de)
|
2013-09-29 |
2015-04-01 |
Audiocure Pharma GmbH |
6-Fluor-9-methyl-ß-carbolin
|
|
WO2015168149A2
(en)
|
2014-04-28 |
2015-11-05 |
Massachusetts Eye & Ear Infirmary |
Sensorineural hair cell differentiation
|
|
KR20170052574A
(ko)
*
|
2014-07-29 |
2017-05-12 |
오토노미, 인코포레이티드 |
이구분해의 치료를 위한 귀 제제
|
|
FR3024361B1
(fr)
|
2014-07-30 |
2017-11-24 |
Affichem |
Utilisation de derives de sterols pour traitement de la perte auditive neurosensorielle et composition correspondante
|
|
EP2982382A1
(en)
|
2014-08-04 |
2016-02-10 |
Sensorion |
Compounds for preventing ototoxicity
|
|
WO2016022776A2
(en)
|
2014-08-06 |
2016-02-11 |
Massachusetts Eye And Ear Infirmary |
Increasing atoh1 life to drive sensorineural hair cell differentiantion
|
|
DE202015100655U1
(de)
*
|
2015-02-03 |
2016-02-04 |
Bio.Lo.Ga. S.R.L. |
Pharmazeutische Zusammensetzung zur topischen Anwendung im Gehörgang
|
|
MX2017010092A
(es)
|
2015-02-11 |
2018-06-06 |
Support Venture Gmbh |
Método para prevenir o tratar la pérdida de la audición.
|
|
JO3491B1
(ar)
|
2015-07-07 |
2020-07-05 |
Audion Therapeutics |
مركبات مثبطة لإشارات مسار notch
|